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INTRODUCTION
It is necessary to obtain a histological sample of 
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Objective: The purpose of this study was to investigate retrospectively the clinical procedural performance of CT-guided 
needle biopsy for retroperitoneal lesions.
Materials and Methods: CT-guided needle biopsy was performed in 74 consecutive patients (M:F = 44:30; mean age, 59.7 
years) with retroperitoneal lesions between April 1998 and June 2009. The target lesion ranged from 1.5 to 12.5 cm in 
size. The biopsy access path ranged from 3.5 to 11.5 cm in depth. A biopsy specimen was obtained using an 18-gauge core 
needle under a CT or CT-fluoroscopy guidance and with the patient under local anesthesia. The histopathological diagnoses 
from the biopsies were obtained. The diagnostic confirmation of the subtype of lymphoma was evaluated.
Results: Satisfactory biopsy samples were obtained in 73 (99%) of 74 patients and a pathological diagnosis was made 
in 70 (95%) of 74 patients. Sixty three lesions were malignant (45 lymphomas, nine primary tumors, nine lymph node 
metastases) and seven were benign. The subtype of lymphoma was specified in 43 (96%) of 45 patients who were 
diagnosed with lymphoma. Analysis of the value of CT-guided biopsy in this series indicated 63 true positives, zero false 
positive, six true negatives and five false negatives. This test had a sensitivity of 93%, a specificity of 100% and an 
accuracy of 93%. No major complications were seen and minor complications were noted in seven patients (five with local 
hematomas, two with transient pain at the puncture site).
Conclusion: CT-guided needle biopsy for retroperitoneal lesions is highly practical and useful, and particularly for 
determining the subtypes in patients with lymphoma.
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undiagnosed lesions for the planning of further therapies. 
Surgical or percutaneous biopsy is a critical part of the 
diagnosis, staging and follow up of suspected or known 
malignancies. Previously, a surgical biopsy was necessary to 
obtain sufficient tissue for making the pathologic diagnosis, 
but this is invasive and associated with morbidity (1). 
Therefore, image-guided percutaneous biopsy procedures 
are increasing being used due to their less invasive nature, 
the lower complication rate and the lower cost as compared 
with surgical methods.
CT-guided biopsy has been widely accepted as an effective 
and safe procedure to confirm the diagnosis in many clinical 
settings (2-5). The advantage of CT guidance is that the 
whole abdomen and retroperitoneum are visualized, and Korean J Radiol 12(3), May/Jun 2011 kjronline.org 352
CT-Guided Needle Biopsy for Retroperitoneal Lesions 
paravertebral area. The biopsy access path ranged from 3.5 
to 11.5 cm in depth (mean, 8.6 cm).
Biopsy Procedure
The criteria for CT-guided biopsy were 1) an undiagnosed 
lesion was found that clinically required a confirmative 
histopathologic diagnosis by biopsy, 2) the puncture path 
to the lesions as a safe approach was confirmed on CT and 3) 
consent from the patient was obtained.
The objects of CT-guided biopsy were lesions with a 
confirmed linear puncture path that was safe without 
interruption by major vessels and bowel when it was 
impossible to perform US-guided biopsy. Contrast enhanced 
CT scans were available prior to the biopsy procedure 
to determine the exact tumor location, the degree of 
vascularity and the presence of necrosis, and to avoid major 
vessels and bowel adjacent to the lesion. 
The exclusion criterion was a bleeding tendency. The 
prothrombin time (PT), activated partial thromboplastin 
time (APTT) and platelet counts were also routinely 
obtained to rule out any bleeding tendency, and the relative 
contraindications included platelet counts < 50,000/mL, a 
PT > 15 sec and an APTT > 39 sec. 
All 74 patients satisfied the criteria. All the biopsies were 
performed under conscious sedation and local anesthesia. 
The position of the patient was chosen on the basis of 
previous CT imaging and a survey CT scan was performed 
before the biopsy to determine the puncture site and 
the linear needle path as a safe approach with using a 
tracking scale. The biopsy procedure was performed under 
conventional CT guidance in nine cases and CT fluoroscopic 
guidance in 65 cases (Fig. 1). The tandem technique was 
used for the conventional CT guidance. An initial 23- or 
21-gauge needle was placed and this was followed by the 
puncture of the biopsy needle in tandem alongside the 
initial needle, and as visualized by sequential CT guidance. 
For the CT fluoroscopy guidance, an I-I device (Hakko, 
Tokyo, Japan) was used, which is a needle holder, and 
the biopsy needle was directly punctured and advanced 
toward the target under intermittent CT fluoroscopy (9). 
Immediately after the biopsy, CT scans were routinely 
obtained for the assessment of acute complications such 
as bleeding, and the patients remained in hospital for 
at least 12 hours for observation to assess any delayed 
complications.
A biopsy specimen was obtained using an 18-gauge core 
biopsy needle. A Fine-Core disposable semiauto biopsy 
this allows accurate planning of a biopsy for deep-seated 
lesions such as retroperitoneal lymphadenopathy and it 
avoids damage to important organs and major vessels. 
In the recent years, the efficacy of CT-guided biopsy for 
making the pathological diagnosis of lymphoma has been 
reported as both the biopsy techniques and the histological 
diagnostic techniques have dramatically improved (6-8). 
Yet in cases of intraperitoneal or retroperitoneal lymphoma, 
there is a tendency for surgical biopsy to be performed 
at most institutions to obtain an adequate specimen for 
specification of the subtype. The purpose of this study 
was to retrospectively investigate the clinical procedural 
performance of a CT-guided needle biopsy for retroperitoneal 
lesions. We verified the usefulness of CT-guided biopsy for 
retroperitoneal lesions, which was reported in previous 
studies. We especially evaluated the diagnostic confirmation 
of the subtype of lymphoma.
MATERIALS AND METHODS
Patients
Between April 1998 and June 2009, CT guided needle 
biopsies were performed in 74 consecutive patients (M:F 
= 44:30) at our hospital with retroperitoneal lesions due 
to the suspicion of malignant lymphoma, lymph node 
metastasis or primary tumor. The mean patient age was 59.7 
years (range, 18-80 years). All the patients were biopsied 
as inpatients and they were observed for at least 12 hours 
after the biopsy. This retrospective review of collected data 
was approved by the ethics committee at our institution.
Over the same period, ultrasound (US)-guided biopsy for 
retroperitoneal lesions was performed for 96 patients and 
surgical biopsy was done for seven. Accordingly, a total of 
177 biopsies were performed for determining retroperitoneal 
lesions.
Materials
The maximum diameter of the target lesion ranged from 
1.5 to 12.5 cm in size (mean size, 5.1 cm). Of the 74 
patients, the lesions were smaller than 3 cm in 27 patients, 
between 3 and 6 cm in 23 patients and larger than 6 cm in 
24 patients.
The 74 lesions for which biopsies were performed varied 
widely in location. Forty nine were paraaortic, seven 
were retrocaval, six were within or adjacent to the psoas 
muscle, four were in the iliac region, three were in the 
presacral space and five were in other locations such as the Korean J Radiol 12(3), May/Jun 2011 kjronline.org 353
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needle (Toray, Tokyo, Japan) was used in 50 cases and a 
Biopty-Cut disposable core biopsy needle (Bard, Covington, 
GA) driven by a spring-loaded Bard MAGNUM biopsy 
instrument was used in the remaining 24 cases. All the 
biopsies were performed using an interventional CT system 
that had a unified CT and angiography unit made by Toshiba 
Medical Systems (X-vigar from 1998 to 2008 or Aquilion 
after 2009 combined with TSX-201A).
Histological Analysis
Technical success was defined as collecting a tissue 
sample that was adequate for the diagnosis. The biopsy 
sample was determined to be either representative or 
nonrepresentative and the amount of biopsy material was 
graded either sufficient or insufficient for diagnostic use by 
a pathologist.
The histological results were based on the interpretation 
of the biopsy sample, and the sample was prepared by the 
standard techniques used in the pathology department 
of our hospital. The sample was usually analyzed with 
Hematoxylin and Eosin stain and other stains as required. 
When lymphoma was suspected, an extended panel 
of immunohistochemical stains was performed. The 
histopathological diagnosis from the CT-guided biopsies 
was compared with the final diagnosis made from the 
clinical and radiologic follow-up or the surgery, if available. 
The following criteria were applied for the statistical 
analysis of our histological results. A true positive was 
defined as histopathologically confirmed malignancy. A 
true negative was defined as there being no malignant 
A B
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Fig. 1. 53-year-old man with paraaortic lesion.
A. Diagnostic axial contrast enhanced CT scan that was obtained prior to biopsy procedure with patient in supine position shows 2-cm paraaortic 
mass lesion (arrow). B. Initial axial CT scan obtained with patient in prone position shows tracking scale crossing retrocaval mass lesion. 
Distance from skin to leading edge of lesion was 10 cm. C. CT fluoroscopic image obtained during biopsy procedure shows safe insertion of biopsy 
needle (arrow) into lesion. Pathologic diagnosis was nodular sclerosis of Hodgkin’s disease. D. CT scan immediately after two punctures reveals 
no complications. Korean J Radiol 12(3), May/Jun 2011 kjronline.org 354
CT-Guided Needle Biopsy for Retroperitoneal Lesions 
signs in the histological samples or any remarkable change 
during the follow-up period. A false positive was defined 
as a histopathologically falsely diagnosed malignancy. A 
false negative was defined as cases where a lesion that 
was diagnosed as not being a malignancy had shown a 
malignant appearance such as rapid growth or invasive 
grown when observed on follow-up CT. Nonrepresentative or 
insufficient samples were also considered as false negatives. 
The diagnostic sensitivity, specificity and accuracy were 
calculated using these definitions.
RESULTS
The CT-guided biopsies of the retroperitoneal lesions 
were technically successful in all the patients. The biopsy 
procedure was performed with an anterior approach with 
the patient in the anterior oblique position for three 
patients and with a posterior approach with the patient in 
the prone position for 71 patients. Each patient received 
a mean of 2.0 punctures (range: 1-4 punctures) per one 
biopsy. The pathological diagnosis was made for 70 (95%) 
of 74 patients. In the remaining four cases, the sample 
was either nonrepresentative (n = 3) or insufficient (n = 
1). These lesions were a mean of 4.1 cm in size and the 
biopsy access path was a mean of 10.2 cm in depth. Of the 
70 cases with a pathologic diagnosis, 63 were malignant 
and seven were benign. Among the malignant cases, 45 
were diagnosed as lymphomas, nine were diagnosed as 
lymph node metastases and nine were diagnosed as primary 
tumors. The primary tumors in the nine cases included 
liposarcoma in two, and rhabdomyosarcoma, malignant 
peripheral nerve sheath tumor, primitive neuroectodermal 
tumor, malignant schwannoma and local recurrence of 
rectal cancer in one patient each, with the remaining two 
cases being diagnosed as sarcoma that could not be sub-
classified anymore. The subtype was specified according to 
the WHO classification in 43 of 45 patients (96%) who were 
diagnosed as having lymphoma (Table 1). Among the benign 
seven cases, five were diagnosed as benign tumors, which 
were schwannoma (n = 4) and angiomyolipoma (n = 1), and 
the remaining two cases were reactive lymphadenopathy. 
No major complications defined as those requiring surgery 
or medical intervention were seen in any of the patients 
either during or after the procedure. Minor complications 
were seen in seven patients. Five patients developed small 
retroperitoneal hematomas in the psoas muscle (n = 3) and 
Table 1. Histological Classification of Lymphomas on CT-
Guided Needle Biopsies  
Non-Hodgkin’s Lymphoma (n = 42)
Follicular lymphoma 22
Diffuse large B-cell lymphoma 14
MALT lymphoma 2
Peripheral T-cell lymphoma 1
Precursor T-cell lymphoblastic lymphoma 1
Lymphoplasmacytic lymphoma 1
B-cell chronic lymphocytic leukemia/small 
lymphocytic lymphoma
1
Hodgkin’s disease (n = 1)
Nodular sclerosis 1
Note.— MALT = mucosa-associated lymphoid tissue
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Fig. 2. 56-year-old man with paraaortic lesion.
A. Diagnostic axial contrast enhanced CT scan obtained prior to biopsy procedure with patient in supine position shows 3-cm paraaortic mass 
lesion (arrow). B. CT scan immediately after two punctures by posterior approach for biopsy reveals retroperitoneal hematoma (arrow).Korean J Radiol 12(3), May/Jun 2011 kjronline.org 355
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adjacent to the psoas muscle (n = 2) that were detected 
on CT scans just after the biopsies (Fig. 2). In these five 
patients, the mean number of punctures per biopsy was 2.2 
times. All of the five patients were completely asymptomatic 
and they did not require a blood transfusion. The remaining 
two patients had transient pain at the puncture site with a 
mean 1.5 times of puncture. The CT scans just after biopsy 
did not reveal any marked abnormality and the pain was 
gradually relieved without medications.
The 70 diagnoses obtained by the biopsy were finally 
confirmed by surgical resection (n = 4) or clinical and 
imaging follow-up for more than six months (n = 66). Of 
the seven cases diagnosed as benign, six remained stable 
on follow-up CT scans that were done between nine and 
92 months (median time, 40.6 months) after the CT-guided 
biopsy, but the remaining one was diagnosed as reactive 
lymphoadenopathy, and it had gradually increased in size 
during the follow-up and it was clinically diagnosed as 
lymph node metastasis of sigmoid colon cancer. The four 
undiagnosed lesions proved to be malignant by re-biopsy  
(n = 1) and follow-up imaging (n = 3).
Analysis of the value of CT-guided biopsy in this series 
indicated 63 true positives, zero false positives, six 
true negatives and five false negatives (including three 
nonrepresentative samples and one insufficient sample). 
The sensitivity was 93%, the specificity was 100% and the 
accuracy was 93%.
DISCUSSION
The safety of percutaneous CT-guided needle biopsy is 
well documented (10, 11). The mass lesions that develop in 
the retroperitoneal space are usually shielded by the aorta, 
inferior vena cava, kidney, bowel and/or other structures. CT 
guidance helps to identify and avoid these major structures 
adjacent to the target biopsy site. As the contraindications 
to CT-guided biopsy, the lack of patient cooperation, 
coagulation problems and technical impossibility due to 
interruption by major vessels and bowel are noted. As a 
rule, we decided through discussions with physicians that 
CT-guided biopsy was not indicated in a case that the 
envisaged path direction was not considered to be safe 
due to interruption by major vessels, bowel and vertebral 
bodies adjacent to the target lesions. For the case that the 
maximum diameter of the target lesion was less than 1 cm, 
we also considered that CT-guided biopsy had poor accuracy 
to biopsy such a small mass and there was an increased 
risk. 
In this study, we could obtain enough specimens from 
the small lesions located at a deep site with the patient 
under local anesthesia and without major complications. 
Among the retroperitoneal lesions for which the US-guided 
approach was considered to be difficult, it was possible to 
perform CT-guided biopsy in 74 patients (91%), although 
eventually surgical biopsy was performed in seven.
A satisfactory sample for histological examination is 
fundamental for making the diagnosis and managing 
lymphomas (12). Core needle biopsies were superior to 
fine needle aspiration biopsies for diagnosing lymphomas 
because a core needle can acquire a relatively large 
specimen and this allows better immunohistochemical 
staining. It was possible to use a CT-guided biopsy to 
make the specific diagnosis of the lymphoma type in most 
cases and it played a very important role to determine 
the treatment modalities. Knelson et al. (13) reviewed CT-
guided needle biopsy for retroperitoneal lesions, and both 
the diagnosis and the histological sub-typing of lymphoma 
could be determined in 10 of 11 cases using the 14-gauge 
Tru-Cut needle, but it was not possible to make the specific 
diagnosis in any of the lymphoma patients using the 20-
gauge Chiba needle. Agid et al. (14) reported that CT-guided 
core needle biopsies were sufficient to establish a diagnosis 
in 83% of the patients with lympho-proliferative disorders 
and they suggested that it should be used as the first step 
in the diagnosis of lymphomas. Stattaus et al. (15) reported 
that the correct lymphoma subtype could be revealed for 
retroperitoneal masses in 87% of the patients by using a 16 
or 18-gauge core biopsy system with the coaxial technique 
under CT guidance. In our study, 43 (96%) of 45 patients 
had a defined diagnosis and the correct histological 
subtype was determined via an 18-gauge core needle and 
the subsequent treatment was performed on the basis of 
the results of the biopsy. Our results might be better as 
compared with those of the previous reports because the 
development of CT fluoroscopy, which enables continuous 
visualization of the needle during biopsy and improved the 
CT-guided needle biopsy procedures (16). Cheung et al. (17) 
recently reported the usefulness of combined fluoroscopy- 
and CT-guided biopsy. De Bazelaire et al. (18) described 
that a coaxial introducer provided with an additional blunt-
tip stylet allows safe access to difficult-to-reach lymph 
nodes in the chest, abdomen and pelvis under CT control. 
CT-guided biopsy using this blunt-tip coaxial introducer 
might be possible even though there are major vessels and Korean J Radiol 12(3), May/Jun 2011 kjronline.org 356
CT-Guided Needle Biopsy for Retroperitoneal Lesions 
bowel adjacent to the target lesions.
US and magnetic resonance imaging (MRI) can be used 
similar to other imaging equipment, in addition to CT 
guidance. US-guided biopsies are faster and more cost-
effective than CT-guided biopsies, and US-guided biopsies 
have established accuracy (19, 20). However, the field 
of view of US-guided biopsy is smaller than that of CT, 
and this often makes it difficult to continuously localize 
retroperitoneal lesions and to sufficiently control the 
needle track (21). MRI, similar to US, has no influence 
of irradiation. MRI has recently developed into a potent 
alternative modality for guiding such procedures and there 
are already numerous reports of different procedures, 
including abdominal biopsies guided by MRI (22-25). 
Zangos et al. (24) described that MRI guidance to perform 
retroperitoneal biopsy should be justified based on a better 
practicability of the biopsy procedure with its superior soft 
tissue contrast and multiplanar imaging capabilities, and 
infants would especially benefit from MRI-guided biopsy 
due to the lack of a radiation burden (23). But there are 
technical difficulties involved in punctures that require the 
use of open-configuration MRI techniques (24), and the 
cost of MRI-guided biopsy is more expensive compared with 
that of CT-guided biopsy due to the higher material costs 
for the MRI-compatible biopsy needles (25). MRI guidance 
lacks real-time imaging and this might lead to a prolonged 
and cumbersome procedure in an incremental fashion (24). 
We have no open-configuration MRI system and we won’t 
talk about it any more. We believe the CT-guided approach 
is better for retroperitoneal lesions because of its wide field 
of view and clear visualization, although the CT-guided 
approach involves radiation exposure.
This study has some limitations such as a case-selection 
bias. We did not know the real number of retroperitoneal 
lesions that required a pathologic diagnosis at our hospital. 
We did not perform biopsy for every retroperitoneal lesion 
that required a pathologic diagnosis. We eventually decided 
in advance whether biopsy could be performed safely, on 
the basis of CT findings, after physicians thought it might 
be possible to perform a CT-guided biopsy for the lesion. 
It remains unclear whether a CT-guided biopsy for every 
retroperitoneal lesion is achievable.
In conclusion, our results indicate that the technique of 
CT-guided needle biopsy provides accurate and safe access 
to retroperitoneal lesions because of its high success and 
low complication rate. This technique is highly practical 
and useful and particularly for patients with suspected 
lymphoma. 
REFERENCES
 1. Hopper KD. Percutaneous, radiographically guided biopsy: a 
history. Radiology 1995;196:329-333
 2. Gazelle GS, Haaga JR. Guided percutaneous biopsy of 
intraabdominal lesions. AJR Am J Roentgenol 1989;153:929-
935
 3. Ben-Yehuda D, Polliack A, Okon E, Sherman Y, Fields S, 
Lebenshart P, et al. Image-guided core-needle biopsy in 
malignant lymphoma: experience with 100 patients that 
suggests the technique is reliable. J Clin Oncol 1996;14:2431-
2434
 4. Guimaraes AC, Chapchap P, de Camargo B, Chojniak R. 
Computed tomography-guided needle biopsies in pediatric 
oncology. J Pediatr Surg 2003;38:1066-1068
 5. Husband JE, Golding SJ. The role of computed tomography-
guided needle biopsy in an oncology service. Clin Radiol 
1983;34:255-260
 6. Sklair-Levy M, Polliack A, Shaham D, Applbaum YH, Gillis S, 
Ben-Yehuda D, et al. CT-guided core-needle biopsy in the 
diagnosis of mediastinal lymphoma. Eur Radiol 2000;10:714-
718
 7. Demharter J, Muller P, Wagner T, Schlimok G, Haude K, 
Bohndorf K. Percutaneous core-needle biopsy of enlarged 
lymph nodes in the diagnosis and subclassification of 
malignant lymphomas. Eur Radiol 2001;11:276-283
 8. Pappa VI, Hussain HK, Reznek RH, Whelan J, Norton AJ, 
Wilson AM, et al. Role of image-guided core-needle biopsy 
in the management of patients with lymphoma. J Clin Oncol 
1996;14:2427-2430
 9. Irie T, Kajitani M, Matsueda K, Arai Y, Inaba Y, Kujiraoka Y, 
et al. Biopsy of lung nodules with use of I-I device under 
intermittent CT fluoroscopic guidance: preliminary clinical 
study. J Vasc Interv Radiol 2001;12:215-219
10. Welch TJ, Sheedy PF 2nd, Johnson CD, Johnson CM, Stephens 
DH. CT-guided biopsy: prospective analysis of 1,000 
procedures. Radiology 1989;171:493-496
11. Chojniak R, Isberner RK, Viana LM, Yu LS, Aita AA, Soares FA. 
Computed tomography guided needle biopsy: experience from 
1,300 procedures. Sao Paulo Med J 2006;124:10-14
12. Libicher M, Noldge G, Radeleff B, Gholipur F, Richter GM. 
Value of CT-guided biopsy in malignant lymphoma. Radiologe 
2002;42:1009-1012
13. Knelson M, Haaga J, Lazarus H, Ghosh C, Abdul-Karim F, 
Sorenson K. Computed tomography-guided retroperitoneal 
biopsies. J Clin Oncol 1989;7:1169-1173
14. Agid R, Sklair-Levy M, Bloom AI, Lieberman S, Polliack A, 
Ben-Yehuda D, et al. CT-guided biopsy with cutting-edge 
needle for the diagnosis of malignant lymphoma: experience 
of 267 biopsies. Clin Radiol 2003;58:143-147
15. Stattaus J, Kalkmann J, Kuehl H, Metz KA, Nowrousian MR, 
Forsting M, et al. Diagnostic yield of computed tomography-Korean J Radiol 12(3), May/Jun 2011 kjronline.org 357
Tomozawa et al.
guided coaxial core biopsy of undetermined masses in the free 
retroperitoneal space: single-center experience. Cardiovasc 
Intervent Radiol 2008;31:919-925
16. Carlson SK, Felmlee JP, Bender CE, Ehman RL, Classic KL, 
Hoskin TL, et al. CT fluoroscopy-guided biopsy of the lung or 
upper abdomen with a breath-hold monitoring and feedback 
system: a prospective randomized controlled clinical trial. 
Radiology 2005;237:701-708
17. Cheung JY, Kim Y, Shim SS, Lim SM. Combined fluoroscopy- 
and CT-guided transthoracic needle biopsy using a C-arm 
cone-beam CT system: comparison with fluoroscopy-guided 
biopsy. Korean J Radiol 2011;12:89-96
18. de Bazelaire C, Farges C, Mathieu O, Zagdanski AM, Bourrier P, 
Frija J, et al. Blunt-tip coaxial introducer: a revisited tool for 
difficult CT-guided biopsy in the chest and abdomen. AJR Am 
J Roentgenol 2009;193:W144-148
19. Memel DS, Dodd GD 3rd, Esola CC. Efficacy of sonography 
as a guidance technique for biopsy of abdominal, pelvic, 
and retroperitoneal lymph nodes. AJR Am J Roentgenol 
1996;167:957-962
20. al-Mofleh IA. Ultrasound-guided fine needle aspiration of 
retroperitoneal, abdominal and pelvic lymph nodes. Diagnostic 
reliability. Acta Cytol 1992;36:413-415
21. Adam G, Bucker A, Nolte-Ernsting C, Tacke J, Gunther RW. 
Interventional MR imaging: percutaneous abdominal and 
skeletal biopsies and drainages of the abdomen. Eur Radiol 
1999;9:1471-1478
22. Lee MH, Lufkin RB, Borges A, Lu DS, Sinha S, Farahani K, et 
al. MR-guided procedures using contemporaneous imaging 
frameless stereotaxis in an open-configuration system. J 
Comput Assist Tomogr 1998;22:998-1005
23. Kariniemi J, Blanco Sequeiros R, Ojala R, Tervonen O. MRI-
guided abdominal biopsy in a 0.23-T open-configuration MRI 
system. Eur Radiol 2005;15:1256-1262
24. Zangos S, Eichler K, Wetter A, Lehnert T, Hammerstingl 
R, Diebold T, et al. MR-guided biopsies of lesions in the 
retroperitoneal space: technique and results. Eur Radiol 
2006;16:307-312
25. Alanen J, Keski-Nisula L, Blanco-Sequeiros R, Tervonen O. Cost 
comparison analysis of low-field (0.23 T) MRI- and CT-guided 
bone biopsies. Eur Radiol 2004;14:123-128